Metagenics

In 1983, the Katke brothers—specifically Jeff and Mike Katke—founded Metagenics in California. The company was built on a simple premise that was ahead of its time: that diet, lifestyle, and nutrition could influence how a person's genes express themselves. They bypassed the crowded consumer supplement aisle, focusing instead on a practitioner channel. They sold their science-backed nutritional formulas and medical foods directly to doctors, chiropractors, and other healthcare professionals who would then recommend them to patients. This strategy of focusing on the practitioner channel proved to be a key decision. It allowed the company to build a trusted brand based on scientific validation and quality, differentiating it from competitors who were seen more as marketing companies. This model fueled steady growth, establishing Metagenics as a leader in its niche. A significant event in the company's journey occurred in 2009 when Alticor, the parent company of Amway, acquired a majority stake in Metagenics. This move provided an opportunity for expansion and for some early shareholders to cash out. The story continued with another major transition in late 2021, when private equity firm Gryphon Investors acquired Metagenics from Alticor, aiming to support the brand's long-term global growth.